...
首页> 外文期刊>The Journal of Nuclear Medicine >Evaluation of D-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with L- and D-11C-methionine.
【24h】

Evaluation of D-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with L- and D-11C-methionine.

机译:O-11C-甲基酪氨酸和O-18F-氟甲基酪氨酸的D-异构体作为荷瘤小鼠中肿瘤显像剂的评估:与L-和D-11C-蛋氨酸的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to investigate whether D-amino acid isomers of O-(11)C-methyl tyrosine ((11)C-CMT) and O-(18)F-fluoromethyl tyrosine ((18)F-FMT) were better than the corresponding L-isomers as tumor- detecting agents with PET in comparison with the difference between L- and D-methyl-(11)C-methionine ((11)C-MET). METHODS: L- and D-(11)C-MET, (11)C-CMT, and (18)F-FMT were injected intravenously into BALB/cA Jcl-nu mice bearing HeLa tumor cells. At 5, 15, 30, and 60 min after injection, normal abdominal organs and xenotransplanted HeLa cells were sampled, and the uptake of each ligand was determined. Metabolic analyses of these compounds in the plasma were also performed. Accumulation of the d-isomers of (11)C-MET, (11)C-CMT, and (18)F-FMT in turpentine-induced inflammatory tissue was assayed in comparison with (18)F-FDG. The whole-body distribution of each tracer was imaged with a planar positron imaging system (PPIS). RESULTS: Although the tumor uptake (standardized uptake value [SUV]) levels of the D-isomers of (11)C-MET, (11)C-CMT, and (18)F-FMT were 261%, 72%, and 95% of each L-isomer 60 min after administration, the tumor-to-blood ratios of these D-isomers were 130%, 140%, and 182% of the corresponding L-isomers. In the blood, the D-isomers of these labeled compounds revealed a relatively faster elimination rate compared with their L-isomers, with a high peak uptake in the blood and kidney 5 min after administration. Compared with the natural amino acid ligand l-(11)C-MET, the uptake of L-isomers of (11)C-CMT and (18)F-FMT was relatively low and stable in the abdominal organs, whereas D-isomers revealed much lower levels and faster clearance rates compared with corresponding L-isomers. Among the abdominal organs, the pancreas showed a relatively high uptake of (11)C-CMT and (18)F-FMT; the uptake of these D-isomers was much lower than that of L-isomers. Pretreatment with cycloheximide, a protein synthesis inhibitor, resulted in a marked reduction of L-(11)C-MET uptake and a slight reduction of D-(11)C-MET uptake into protein fractions, whereas no significant changes were detected with L- and D-(11)C-CMT and (18)F-FMT. D-Isomers of (11)C-MET, (11)C-CMT, and (18)F-FMT did not accumulate in turpentine-induced inflammatory tissue, where (18)F-FDG revealed a high uptake. Whole-body imaging with a PPIS provided consistent distribution data obtained from the tissue dissection analysis. CONCLUSION: These results suggest that D-isomers of (11)C-CMT and (18)F-FMT could be potentially better tracers than L- and D-(11)C-MET for tumor imaging with PET.
机译:这项研究的目的是调查是否O-(11)C-甲基酪氨酸((11)C-CMT)和O-(18)F-氟甲基酪氨酸((18)F-FMT)的D-氨基酸异构体与L-和D-甲基-(11)C-甲硫氨酸((11)C-MET)之间的差异相比,作为PET的肿瘤检测剂,它们比相应的L-异构体更好。方法:将L-和D-(11)C-MET,(11)C-CMT和(18)F-FMT静脉注射到带有HeLa肿瘤细胞的BALB / cA Jcl-nu小鼠中。注射后第5、15、30和60分钟,对正常的腹部器官和异种移植的HeLa细胞进行采样,并确定每种配体的摄取。还对血浆中这些化合物进行了代谢分析。与(18)F-FDG相比,测定了松节油诱导的炎性组织中(11)C-MET,(11)C-CMT和(18)F-FMT的d-异构体的积累。使用平面正电子成像系统(PPIS)对每个示踪剂的全身分布进行成像。结果:尽管(11)C-MET,(11)C-CMT和(18)F-FMT的D-异构体的肿瘤摄取(标准摄取值[SUV])水平分别为261%,72%和给药后60分钟,每种L-异构体的95%,这些D-异构体的肿瘤血比分别为相应L-异构体的130%,140%和182%。在血液中,这些标记化合物的D异构体与其L异构体相比具有相对更快的消除速度,给药后5分钟在血液和肾脏中的吸收峰值较高。与天然氨基酸配体l-(11)C-MET相比,(11)C-CMT和(18)F-FMT的L-异构体在腹部器官的摄取相对较低且稳定,而D-异构体与相应的L-异构体相比,它具有更低的水平和更快的清除速率。在腹腔器官中,胰腺对(11)C-CMT和(18)F-FMT的吸收较高。这些D-异构体的吸收远低于L-异构体。用蛋白质合成抑制剂环己酰亚胺预处理可显着降低L-(11)C-MET的摄取,并略微减少D-(11)C-MET摄取的蛋白质级分,而L并未检测到显着变化-和D-(11)C-CMT和(18)F-FMT。 (11)C-MET,(11)C-CMT和(18)F-FMT的D-异构体未积累在松节油诱导的炎症组织中,其中(18)F-FDG显示出高摄取。使用PPIS进行的全身成像可提供从组织解剖分析获得的一致分布数据。结论:这些结果表明(11)C-CMT和(18)F-FMT的D-异构体可能比L-和D-(11)C-MET在PET显像中可能更好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号